Lonza  
Careers @ Lonza | Contact us | Sitemap |
Shop
 
Home > Company > Media Center > News Archive > 2009
 
News 2009
send     print    
Language


Date of Publication Title Media Releases Financial Reports Presen-tations
12/15/2009 Femta Pharmaceuticals and Lonza enter into manufacturing services agreement 091215_Femta_e_final.pdf
11/25/2009 Lonza and Micromet Enter into Agreement for the Manufacture of Blinatumomab 091125_Micromet_e_final.pdf
11/10/2009 Lonza successfully develops a manufacturing process for ArzerraTM 091110_GSK_Arzerra_e_final.pdf
11/10/2009 Lonza Receives Technology Leadership of the Year Award from Frost and Sullivan 101109_LonzaNewsRelease_ForstSullivanAward.pdf
11/10/2009 Lonza Provides Disinfectant Industry with Formulations to Combat H1N1 091104_Lonza_USA_H1N1.pdf
11/05/2009 ProChon Biotech Selects Lonza 091105_ProChon_e_final.pdf
11/03/2009 Lonza Acquires Biotech Service Provider Algonomics 091103_Algonomics_e_final.pdf
11/03/2009 Personnel Changes in Investor Relations 091103_IR_changes_e_final.pdf
10/29/2009 Lonza Business Update Third Quarter 2009 091029_Q3_Update_e_final.pdf 2009_Third Quarter Trading Update final.pdf
10/22/2009 Lonza acquires stake in Cilian AG 091022_Cilian_investment_e_final.pdf
10/22/2009 Conference Call - Business Update Third Quarter 2009
10/21/2009 Lonza and Alnara enter manufacturing agreement 091021_Alnara_e_final.pdf
10/20/2009 Lonza Announces Withdrawal of Bid for Patheon 091020_Patheon_withdrawal_e_final.pdf
10/15/2009 Patheon and Lonza Agree to Extend Exclusivity Period 091015_renewed_extension_due_diligence_e_final.pdf
10/13/2009 Lonza expands cell-biology platform 091013_Simbiosys_e_final.pdf
10/12/2009 Lonza and BioWa Introduce Potent New Cell Line 091012_Biowa_ Lonza_cell_line_e_final.pdf
10/05/2009 Head of Global Human Resources leaves Lonza 091005_Step Down_Head_HR_e_final.pdf
10/01/2009 Fight against the H1N1 Virus with Lonza Formulations 091001_H1N1_e_final.pdf
09/28/2009 Extension of Due Diligence Period 090928_Extension_Due_Diligence_e_final.pdf
09/09/2009 New Microbial Control Formulations Plant in Nanjing 090909_Nanjing_FP_e.pdf
09/08/2009 Groundbreaking of the new Cell Therapy facility in Singapore 090908_Cell_Therapy_Singapore_Groundbreaking_e.pdf
08/31/2009 Roche and Lonza Announce Opt-in for Singapore Manufacturing Facility 090831_Genentech_optin_Singapore_e_final.pdf
08/21/2009 Non-binding Proposal to Acquire Patheon 090821_Patheon_offer_e_final.pdf 090821_Patheon_offer_Presentation_final.pdf
08/06/2009 Lonza Successfully Starts Up Second Phase of Nansha API Facility 090806_Nansha_API_2_e_final.pdf
08/04/2009 Lonza statement regarding EPA Region II Press Release of July 31, 2009 090804_EPA_Statement Final.pdf
07/31/2009 Lonza Launches XSpedite Microbial Services™ 090731_NewMicrobialBPMOffering_e_final.pdf
07/31/2009 Personnel Changes in Investor Relations 090731_IR_changes_e_final.pdf
07/22/2009 Half-Year 2009 Results H1 2009 Results_ Media Release_e.pdf 2009_Lonza_HY_Report_e_final.pdf 2009_Half Year Results Final.pdf
07/22/2009 Audio Webcast - Replay HYR 2009
07/21/2009 Consolidation of Custom Manufacturing Businesses 090721_LCM_e_final.pdf
07/15/2009 Lonza and LFB Enter Manufacturing Agreement 090715_LFB_Lonza_e_final.pdf
07/09/2009 Medarex and Lonza Sign Collaboration Agreement 090709_Medarex_e_final.pdf
07/06/2009 4-year convertible bond fully converted 090706_Bond_Converted_e_final.pdf
07/02/2009 Invitation
07/01/2009 Presentation Half Year 2009 Results
06/22/2009 DSM and Lonza renew the collaboration in Visp/Lalden 090622_DSM_Lalden_e_final.pdf
06/16/2009 Elusys Therapeutics and Lonza Enter Into Manufacturing Agreement 090616_Elusys_E_final.pdf
05/29/2009 Change in Visp Site Management 090529_Wechsel Standortleitung Visp final_E.pdf
05/29/2009 Allotment 30 Acres of land in the „Genome Valley“ 090529_genomevalley_e_final.pdf
05/26/2009 Manufacturing contract using its proprietary microreactor technology 090526_Microreactor_e_final.pdf
05/19/2009 Morphotek®, Inc and Lonza into manufacturing services agreement 090519_Morphotek_E_final.pdf
05/15/2009 Lonza expands Cell Therapy business with new facility in Singapore 090515_Cell_Therapy_Singapore_e_final.pdf
05/14/2009 Lonza and Teva Announce Receipt of Regulatory Approval 090514_Teva_Closing_E_final.pdf
04/29/2009 CHF 300 million 4-year straight bond 090429_Bond_E_final.pdf
04/23/2009 2000-liter microbial facility on stream in Hopkinton 090423_Hopkinton_2000l_e_final.pdf
04/23/2009 Business Update Q1/2009 2009_First Quarter Trading Update Final.pdf
04/08/2009 Annual General Meeting of Lonza Group Ltd 090408_GV_e.pdf
04/02/2009 Potent Compound Safety Certification for Manufacturing ADCs 080402_Safebridge_e_final.pdf
04/01/2009 Next Generation Endotoxin Detection Software 090401_Endotoxin_WinKQCL_e_final.pdf
03/24/2009 Lonza Participates in the United Nations Global Compact 090324_UN_Global_Compact_e_final.pdf
03/17/2009 Annual General Meeting
03/17/2009 New Head of Lonza Bioscience 090317_New_Head_LBS_E_final.pdf
03/10/2009 Clonal Cell Line Constructions 090310_New_CLC_e_final.pdf
02/27/2009 Lonza and Opsona enter into manufacturing agreement 090227_Opsona_E_final.pdf
01/27/2009 Lonza Full Year Results 2008 090127_FYR_2008_e_final.pdf 2008_FY_E_final_high.pdf 2008_Full Year Results_pres Final.pdf
01/20/2009 Teva and Lonza Announce Strategic Partnership 090120_Teva_E_final.pdf
01/09/2009 Presentation Financial Year 2008 Results


Disclaimer